We are deepening our impact on human health by serving as a champion for patients, our communities, our people, and the planet
Innovating at the intersection of biology, technology, and health, Illumina is advancing genomics for good to create a healthier, more sustainable, and more equitable future for all. We focus these efforts on five priorities:
Notable recognitions
We are honored to receive recognition for our Corporate Social Responsibility (CSR) efforts. Illumina will continue to strive to be the best employer, the best environmental steward, and the best corporate citizen we can possibly be.
2022 Corporate Social Responsibility Report
Learn about the progress we have made to shape a more sustainable and equitable future for all.
Environmental, Social, and Governance (ESG)
Read our Environmental, Social, and Governance (ESG) policies, download past reports, and review our data.
Read our latest CSR news
Our 2030* goals
*Except where noted otherwise.
Accelerate access to genomics
>2 billion
lives covered by genomic testing globally (2026)
50,000
patients supported through philanthropic iHope program
$100 genome
Integrate sustainability
100%
renewable electricity
Net Zero
carbon emissions by 2050
(46% reduction by 2030)
75%
reduction in packaging
Nurture our people
Increase
gender representation in global workforce and leadership
Maintain
zero net pay gap
Increase
representation of Black, Native, Pacific Islander, Hispanic or Latino, and two or more communities in our US workforce and leadership
Operate responsibly
20%
total spend allocated to diverse suppliers
Position Illumina as the
most trusted
company in genomic privacy and ethics